The project Malopolska Researchers' Night will be implemented in the years 2014 and 2015 respectively for the eighth and ninth time. The event has already permanently inscribed in the calendar of Malopolska scientific events, enjoying growing from year to year popular among participants and becoming one of the biggest Nights in Europe. In 2013, this event was attended by over 55 thousand people, while in the first year of the project (2007) the event was attended only by 3.5 thousand people. The event program specified in the application is even richer than before – it will take over 1 thousand activities, mainly interactive workshops, presentations, demonstrations and experiments as well as shows with the participation of scientists. It is estimated that 60 thousand people will participate in the events in 2014 and 65 thousand people in 2015. Malopolska Researchers' Night is to first of all show participants how interesting is the work of scientists and how fascinating they are people. Through fun, in accessible and understandable way for everybody, we want to show that all around us is the science, and that scientists in their laboratories are working every day to make our life better, easier and more modern. The main motto of the project for the years 2014 and 2015 will be to present the successes of Malopolska scientists working in international scientific-research teams. The event will be held in six cities of the Region: Krakow, Tarnow, Nowy Sacz and Niepolomice and - for the first time in 2014 - also in Skawina and Andrychow. In addition, it is planned the live broadcast from selected locations via event website. The program will be prepared by almost 900 researchers, more than 1 600 students, about 120 research groups from more than 30 partners. Thanks to the extensive promotional campaign the information about the event will reach to nearly 3.5 million people each year.

Development and construction of accelerator based scientific Research Infrastructures are going through a deep paradigm change because of the need for large scale Technological Infrastructures at the forefront of technology to master the key accelerator and magnet science and technology needed for several fields. Indeed, because of the high technological level and of the increased size and time scale of projects, development and construction require more and more sophisticated R&D platforms on key accelerator and magnet technologies, large-scale facilities for their assembly, integration and verification, large concentrations of dedicated skilled personnel and long term relationships between laboratories and industry. In response to those challenges, a few large platforms specialized in interdisciplinary technologies and for applications of direct benefit to society are emerging. The emerging Technological Infrastructure is aiming at creating an efficient integrated ecosystem among laboratories focussed on R&D, with a long term vision for the technological needs of future RIs and industry, including SME, motivated by the innovative environment and the market created by the realisation of the technological needs of several RIs. With a timeline of 30 months, involving 10 Consortium partners, the AMICI proposal will ensure that A) a stronger and optimised integration model between the large existing technological infrastructures is developed and agreed upon, B) that this integrated ecosystem is attracting industries and fostering innovation based on accelerator and SC magnets cutting-edge developments, C) that strategy and roadmaps are clearly defined and understood to strongly position European industries and SMEs on the market of the construction of new Research Infrastructures worldwide, and D) that potential societal applications are identified and disseminated to the relevant partners of this ecosystem.

ImAge-D will train a new generation of Doctoral Candidates (DCs) in the development and application of newly developed high speed and high-resolution imaging tools in biomedical research. The ten DCs will be cross-pollinated with concepts and skills in physics and biomedicine, in particular in super-resolution imaging, analytical image reconstruction, and optical micro-manipulation methods. These skills will be applied to reveal for the first time the functionality and morphology (below the diffraction limit of light) of living endothelial cells (EC) that present the main barrier between the blood/lymph and all organs and tissues, and how these vital cells change with ageing. Very little is known at the nanoscale about extremely important physiological functions of EC and their role in the transfer and/or clearance of metabolites and pharmaceuticals to vital organs, and how EC change with ageing. The current generation of optical nanoscopes, however, is rather slow and can only be applied to isolated, typically fixed (i.e. dead) cells rather than biomedically relevant tissues. Also, newcomers to the field need to familiarize themselves with a whole new set of potential problems that might arise in the use of optical nanoscopy, such as image reconstruction- related artifacts to name just one example.This is an area of research where European enterprises are very active. Excellent training in new scientific and complementary skills, combined with international and intersectoral work experience, will instill an innovative, creative and entrepreneurial mind-set in ImAge-D's DCs, maximising economic benefits based on scientific discoveries. These specialised, highly trained, and mobile DCs will have greatly enhanced career prospects. The training in novel physical methods with highly relevant experience in the biomedical sciences will allow them to confidently navigate at the interface of academic, clinical and private sector research.

DeLIVERY aims to build a radically new technology for personalized health care, which provides, for the first time, the possibility to investigate polypharmacy on individual patients. Polypharmacy is the effect that the many combinations and permutations of drug mixtures which are typically prescribed to the chronically sick or the elderly population (e.g. painkillers, beta blockers, blood thinners, anti-depressants, and statins) have on the human body. Polypharmacy is becoming a major issue in the ageing population, as well over 10% of hospital admissions for people over 60 years of age are due to currently unknown interactions of the multiple drugs being prescribed by the specialized physicians and general practitioners routinely visited by the elderly. Currently, no single platform exists that can be utilized in a highly parallelized fashion to monitor such effects at the cellular and tissue level. DeLIVERY will provide an integrated microphysiological system (MPS) culture and microscopic imaging platform specifically for the purpose of maintaining, treating and long-term imaging of patient-specific cells within their microenvironment. This MPS platform will allow physicians, biomedical scientists, and researchers to determine the individual response of human tissue biopsies to a combination of multiple drugs. DeLIVERY will enable individualized treatment options providing essential tools towards a better quality of life for older people by allowing improved personalized healthcare. Novel medicines with the potential to reverse the effects of ageing and non-alcoholic fatty liver disease (NAFLD) will be tested within typical polypharmacy contexts to determine possible interactions, and the DeLIVERY MPS system will be the purpose-built platform to provide this service. Such a system also requires a paradigm shift in microscopy - away from the single, bulky instrument providing one imaging modality towards compact and modular, yet still high-end, devices.